61 related articles for article (PubMed ID: 38451317)
1. Underlying Mechanisms behind the Brain-Gut-Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update.
De Cól JP; de Lima EP; Pompeu FM; Cressoni Araújo A; de Alvares Goulart R; Bechara MD; Laurindo LF; Méndez-Sánchez N; Barbalho SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612504
[TBL] [Abstract][Full Text] [Related]
2. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
[TBL] [Abstract][Full Text] [Related]
3. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
[TBL] [Abstract][Full Text] [Related]
4. Bile acid profile associated with CSF and PET biomarkers in Alzheimer's disease.
Nabizadeh F; Valizadeh P; Fallahi MS;
Aging Clin Exp Res; 2024 Mar; 36(1):62. PubMed ID: 38451317
[TBL] [Abstract][Full Text] [Related]
5. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Nho K; Kueider-Paisley A; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Jia W; Xie G; Ahmad S; Hankemeier T; van Duijn CM; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R;
Alzheimers Dement; 2019 Feb; 15(2):232-244. PubMed ID: 30337152
[TBL] [Abstract][Full Text] [Related]
6. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
Ben Bouallègue F; Mariano-Goulart D; Payoux P;
Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's Disease Normative Cerebrospinal Fluid Biomarkers Validated in PET Amyloid-β Characterized Subjects from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
Li QX; Villemagne VL; Doecke JD; Rembach A; Sarros S; Varghese S; McGlade A; Laughton KM; Pertile KK; Fowler CJ; Rumble RL; Trounson BO; Taddei K; Rainey-Smith SR; Laws SM; Robertson JS; Evered LA; Silbert B; Ellis KA; Rowe CC; Macaulay SL; Darby D; Martins RN; Ames D; Masters CL; Collins S;
J Alzheimers Dis; 2015; 48(1):175-87. PubMed ID: 26401938
[TBL] [Abstract][Full Text] [Related]
8. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I
J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800
[TBL] [Abstract][Full Text] [Related]
9. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population.
Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC
ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397
[TBL] [Abstract][Full Text] [Related]
10. The Pathological Effects of Circulating Hydrophobic Bile Acids in Alzheimer's Disease.
Ehtezazi T; Rahman K; Davies R; Leach AG
J Alzheimers Dis Rep; 2023; 7(1):173-211. PubMed ID: 36994114
[TBL] [Abstract][Full Text] [Related]
11. The Influence of the Gut Microbiota on Alzheimer's Disease: A Narrative Review.
Yin JT; Xu XW; Jin CY; Yuan XY; Wang XG
J Integr Neurosci; 2023 Feb; 22(2):38. PubMed ID: 36992601
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiome changes due to sleep disruption in older and younger individuals: a case for sarcopenia?
Morwani-Mangnani J; Giannos P; Belzer C; Beekman M; Eline Slagboom P; Prokopidis K
Sleep; 2022 Dec; 45(12):. PubMed ID: 36183306
[TBL] [Abstract][Full Text] [Related]
13. A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction-Related Diseases.
Weng ZB; Chen YR; Lv JT; Wang MX; Chen ZY; Zhou W; Shen XC; Zhan LB; Wang F
Oxid Med Cell Longev; 2022; 2022():4289383. PubMed ID: 35308170
[TBL] [Abstract][Full Text] [Related]
14. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
Mulak A
J Alzheimers Dis; 2021; 84(2):461-477. PubMed ID: 34569953
[TBL] [Abstract][Full Text] [Related]
15. Review: microbial transformations of human bile acids.
Guzior DV; Quinn RA
Microbiome; 2021 Jun; 9(1):140. PubMed ID: 34127070
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
